CXCL10 acts as a bifunctional antimicrobial molecule against Bacillus anthracis

mBio

Volumn 7, Issue 3, 2016, Pages

  Margulieux, Katie R ^a   Fox, Jay W ^a   Nakamoto, Robert K ^a   Hughes, Molly A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; FTSE PROTEIN; FTSX PROTEIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CELL CYCLE PROTEIN; FTSX PROTEIN, BACTERIA; PROTEIN BINDING;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM MUTANT; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; MEMBRANE DAMAGE; MEMBRANE DEPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; ANIMAL; CHEMISTRY; DRUG EFFECTS; GENETICS; HUMAN; MEMBRANE POTENTIAL; METABOLISM; MUTATION; SEQUENCE ALIGNMENT;

ANIMALS; ANTI-BACTERIAL AGENTS; BACILLUS ANTHRACIS; BACTERIAL PROTEINS; CELL CYCLE PROTEINS; CHEMOKINE CXCL10; HUMANS; MEMBRANE POTENTIALS; MUTATION; PROTEIN BINDING; SEQUENCE ALIGNMENT;

EID: 84979073092     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00334-16     Document Type: Article

References (62)

1. Mortality and Causes of Death Collaborators. 2015. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385: 117-171. http://dx.doi.org/10.1016/S0140-6736(14)61682-2.
2. Luster AD. 1998. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338: 436-445. http://dx.doi.org/10.1056/NEJM199802123380706.
3. Bonecchi R, Galliera E, Borroni EM, Corsi MM, Locati M, Mantovani A. 2009. Chemokines and chemokine receptors: an overview. Front Biosci (Landmark Ed) 14: 540-551. http://dx.doi.org/10.2741/3261.
4. Griffith JW, Sokol CL, Luster AD. 2014. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol 32: 659-702. http://dx.doi.org/10.1146/annurev-immunol-032713-120145.
5. Zlotnik A, Yoshie O. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127. http://dx.doi.org/10.1016/S1074-7613(00)80165-X.
6. Zlotnik A, Yoshie O. 2012. The chemokine superfamily revisited. Immunity 36: 705-716. http://dx.doi.org/10.1016/j.immuni.2012.05.008.
7. Allen SJ, Crown SE, Handel TM. 2007. Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 25: 787-820. http://dx.doi.org/10.1146/annurev.immunol.24.021605.090529.
8. Colvin RA, Campanella GS, Manice LA, Luster AD. 2006. CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis. Mol Cell Biol 26: 5838-5849. http://dx.doi.org/10.1128/MCB.00556-06.
9. Vaidehi N, Bhattacharya S, Larsen AB. 2014. Structure and dynamics of G-protein coupled receptors. Adv Exp Med Biol 796: 37-54. http://dx.doi.org/10.1007/978-94-007-7423-0_3.
10. Kufareva I, Salanga CL, Handel TM. 2015. Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies. Immunol Cell Biol 93: 372-383. http://dx.doi.org/10.1038/icb.2015.15.
11. Mehrad B, Keane MP, Strieter RM. 2007. Chemokines as mediators of angiogenesis. Thromb Haemost 97: 755-762. http://dx.doi.org/10.1160/TH07-01-0040.
12. Lacotte S, Brun S, Muller S, Dumortier H. 2009. CXCR3, inflammation, and autoimmune diseases. Ann N Y Acad Sci 1173: 310-317. http://dx.doi.org/10.1111/j.1749-6632.2009.04813.x.
13. Dürr M, Peschel A. 2002. Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense. Infect Immun 70: 6515-6517. http://dx.doi.org/10.1128/IAI.70.12.6515-6517.2002.
14. Cole AM, Ganz T, Liese AM, Burdick MD, Liu L, Strieter RM. 2001. Cutting edge: IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J Immunol 167: 623-627. http://dx.doi.org/10.4049/jimmunol.167.2.623.
15. Oppenheim JJ, Biragyn A, Kwak LW, Yang D. 2003. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann Rheum Dis 62(Suppl 2): ii17-ii21. http://dx.doi.org/10.1136/ard.62.suppl _2.ii17.
16. Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, Oppenheim JJ. 2003. Many chemokines including CCL20/MIP-3α display antimicrobial activity. J Leukoc Biol 74: 448-455. http://dx.doi.org/10.1189/jlb.0103024.
17. Crawford MA, Zhu Y, Green CS, Burdick MD, Sanz P, Alem F, O’Brien AD, Mehrad B, Strieter RM, Hughes MA. 2009. Antimicrobial effects of interferon-inducible CXC chemokines against Bacillus anthracis spores and bacilli. Infect Immun 77: 1664-1678. http://dx.doi.org/10.1128/IAI.01208-08.
18. Reid-Yu SA, Tuinema BR, Small CN, Xing L, Coombes BK. 2015. CXCL9 contributes to antimicrobial protection of the gut during Citrobacter rodentium infection independent of chemokine-receptor signaling. PLoS Pathog 11: e1004648. http://dx.doi.org/10.1371/journal.ppat.1004648.
19. Yung SC, Murphy PM. 2012. Antimicrobial chemokines. Front Immunol 3: 276. http://dx.doi.org/10.3389/fimmu.2012.00276.
20. Van Raemdonck K, Van den Steen PE, Liekens S, Van Damme J, Struyf S. 2015. CXCR3 ligands in disease and therapy. Cytokine Growth Factor Rev 26: 311-327. http://dx.doi.org/10.1016/j.cytogfr.2014.11.009.
21. Schutte KM, Fisher DJ, Burdick MD, Mehrad B, Mathers AJ, Mann BJ, Nakamoto RK, Hughes MA. 2015. Escherichia coli pyruvate dehydrogenase complex is an important component of CXCL10-mediated antimicrobial activity. Infect Immun 84: 320-328. http://dx.doi.org/10.1128/IAI.00552-15.
22. Frederick MJ, Clayman GL. 2001. Chemokines in cancer. Expert Rev Mol Med 3: 1-18. http://dx.doi.org/10.1017/S1462399401003301.
23. Booth V, Keizer DW, Kamphuis MB, Clark-Lewis I, Sykes BD. 2002. The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions. Biochemistry 41: 10418-10425. http://dx.doi.org/10.1021/bi026020q.
24. Trotta T, Costantini S, Colonna G. 2009. Modelling of the membrane receptor CXCR3 and its complexes with CXCL9, CXCL10 and CXCL11 chemokines: putative target for new drug design. Mol Immunol 47: 332-339. http://dx.doi.org/10.1016/j.molimm.2009.09.013.
25. Loetscher M, Loetscher P, Brass N, Meese E, Moser B. 1998. Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization. Eur J Immunol 28: 3696-3705. http://dx.doi.org/10.1002/(SICI)1521-4141(199811)28: 11_3696:: AID-IMMU36963.0.CO; 2-W.
26. Groom JR, Luster AD. 2011. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol 89: 207-215. http://dx.doi.org/10.1038/icb.2010.158.
27. Xanthou G, Williams TJ, Pease JE. 2003. Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation. Eur J Immunol 33: 2927-2936. http://dx.doi.org/10.1002/eji.200324235.
28. Mock M, Fouet A. 2001. Anthrax. Annu Rev Microbiol 55: 647-671. http://dx.doi.org/10.1146/annurev.micro.55.1.647.
29. Spencer RC. 2003. Bacillus anthracis. J Clin Pathol 56: 182-187. http://dx.doi.org/10.1136/jcp.56.3.182.
30. Sweeney DA, Hicks CW, Cui X, Li Y, Eichacker PQ. 2011. Anthrax infection. Am J Respir Crit Care Med 184: 1333-1341. http://dx.doi.org/10.1164/rccm.201102-0209CI.
31. Weiner ZP, Glomski IJ. 2012. Updating perspectives on the initiation of Bacillus anthracis growth and dissemination through its host. Infect Immun 80: 1626-1633. http://dx.doi.org/10.1128/IAI.06061-11.
32. Crawford MA, Burdick MD, Glomski IJ, Boyer AE, Barr JR, Mehrad B, Strieter RM, Hughes MA. 2010. Interferon-inducible CXC chemokines directly contribute to host defense against inhalational anthrax in a murine model of infection. PLoS Pathog 6: e1001199. http://dx.doi.org/10.1371/journal.ppat.1001199.
33. De Smet K, Contreras R. 2005. Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol Lett 27: 1337-1347. http://dx.doi.org/10.1007/s10529-005-0936-5.
34. Chang WK, Wimley WC, Searson PC, Hristova K, Merzlyakov M. 2008. Characterization of antimicrobial peptide activity by electrochemical impedance spectroscopy. Biochim Biophys Acta 1778: 2430-2436. http://dx.doi.org/10.1016/j.bbamem.2008.06.016.
35. Crawford MA, Lowe DE, Fisher DJ, Stibitz S, Plaut RD, Beaber JW, Zemansky J, Mehrad B, Glomski IJ, Strieter RM, Hughes MA. 2011. Identification of the bacterial protein FtsX as a unique target of chemokine-mediated antimicrobial activity against Bacillus anthracis. Proc Natl Acad Sci U S A 108: 17159-17164. http://dx.doi.org/10.1073/pnas.1108495108.
36. de Leeuw E, Graham B, Phillips GJ, ten Hagen-Jongman CM, Oudega B, Luirink J. 1999. Molecular characterization of Escherichia coli FtsE and FtsX. Mol Microbiol 31: 983-993. http://dx.doi.org/10.1046/j.1365-2958.1999.01245.x.
37. Schmidt KL, Peterson ND, Kustusch RJ, Wissel MC, Graham B, Phillips GJ, Weiss DS. 2004. A predicted ABC transporter, FtsEX, is needed for cell division in Escherichia coli. J Bacteriol 186: 785-793. http://dx.doi.org/10.1128/JB.186.3.785-793.2004.
38. Garti-Levi S, Hazan R, Kain J, Fujita M, Ben-Yehuda S. 2008. The FtsEX ABC transporter directs cellular differentiation in Bacillus subtilis. Mol Microbiol 69: 1018-1028. http://dx.doi.org/10.1111/j.1365-2958.2008.06340.x.
39. Domínguez-Cuevas P, Porcelli I, Daniel RA, Errington J. 2013. Differentiated roles for MreB-actin isologues and autolytic enzymes in Bacillus subtilis morphogenesis. Mol Microbiol 89: 1084-1098. http://dx.doi.org/10.1111/mmi.12335.
40. Meisner J, Montero Llopis P, Sham L-T, Garner E, Bernhardt TG, Rudner DZ. 2013. FtsEX is required for CwlO peptidoglycan hydrolase activity during cell wall elongation in Bacillus subtilis. Mol Microbiol 89: 1069-1083. http://dx.doi.org/10.1111/mmi.12330.
41. Mavrici D, Marakalala MJ, Holton JM, Prigozhin DM, Gee CL, Zhang YJ, Rubin EJ, Alber T. 2014. Mycobacterium tuberculosis FtsX extracellular domain activates the peptidoglycan hydrolase, RipC. Proc Natl Acad Sci U S A 111: 8037-8042. http://dx.doi.org/10.1073/pnas.1321812111.
42. Arends SJR, Kustusch RJ, Weiss DS. 2009. ATP-binding site lesions in FtsE impair cell division. J Bacteriol 191: 3772-3784. http://dx.doi.org/10.1128/JB.00179-09.
43. Mir MA, Arumugam M, Mondal S, Rajeswari HS, Ramakumar S, Ajitkumar P. 2015. Mycobacterium tuberculosis cell division protein, FtsE, is an ATPase in dimeric form. Protein J 34: 35-47. http://dx.doi.org/10.1007/s10930-014-9593-7.
44. Kohanski MA, Dwyer DJ, Collins JJ. 2010. How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol 8: 423-435. http://dx.doi.org/10.1038/nrmicro2333.
45. Swaminathan GJ, Holloway DE, Colvin RA, Campanella GK, Papageorgiou AC, Luster AD, Acharya KR. 2003. Crystal structures of oligomeric forms of the IP-10/CXCL10 chemokine. Structure 11: 521-532. http://dx.doi.org/10.1016/S0969-2126(03)00070-4.
46. Campbell DJ, Kim CH, Butcher EC. 2003. Chemokines in the systemic organization of immunity. Immunol Rev 195: 58-71. http://dx.doi.org/10.1034/j.1600-065X.2003.00067.x.
47. Notredame C, Higgins DG, Heringa J. 2000. T-Coffee: a novel method for fast and accurate multiple sequence alignment. J Mol Biol 302: 205-217. http://dx.doi.org/10.1006/jmbi.2000.4042.
48. Di Tommaso P, Moretti S, Xenarios I, Orobitg M, Montanyola A, Chang J-M, Taly J-F, Notredame C. 2011. T-Coffee: a web server for the multiple sequence alignment of protein and RNA sequences using structural information and homology extension. Nucleic Acids Res 39: W13-W17. http://dx.doi.org/10.1093/nar/gkr245.
49. Yang DC, Peters NT, Parzych KR, Uehara T, Markovski M, Bernhardt TG. 2011. An ATP-binding cassette transporter-like complex governs cellwall hydrolysis at the bacterial cytokinetic ring. Proc Natl Acad Sci U S A 108: e1052-60. http://dx.doi.org/10.1073/pnas.1107780108.
50. Shahabuddin S, Ji R, Wang P, Brailoiu E, Dun N, Yang Y, Aksoy MO, Kelsen SG, Aksoy MO, Dun N. 2006. CXCR3 chemokine receptorinduced chemotaxis in human airway epithelial cells: role of p38 MAPK and PI3K signaling pathways. Am J Physiol Cell Physiol 291: C34-C39. http://dx.doi.org/10.1152/ajpcell.00441.2005.
51. Greenfield NJ. 2006. Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc 1: 2876-2890. http://dx.doi.org/10.1038/nprot.2006.202.
52. Janes BK, Stibitz S. 2006. Routine markerless gene replacement in Bacillus anthracis. Infect Immun 74: 1949-1953. http://dx.doi.org/10.1128/IAI.74.3.1949-1953.2006.
53. Sham LT, Jensen KR, Bruce KE, Winkler ME. 2013. Involvement of FtsE ATPase and FtsX extracellular loops 1 and 2 in FtsEX-PcsB complex function in cell division of Streptococcus pneumoniae D39. mBio 4: e00431-13. http://dx.doi.org/10.1128/mBio.00431-13.
54. Mir MA, Rajeswari HS, Veeraraghavan U, Ajitkumar P. 2006. Molecular characterisation of ABC transporter type FtsE and FtsX proteins of Mycobacterium tuberculosis. Arch Microbiol 185: 147-158. http://dx.doi.org/10.1007/s00203-005-0079-z.
55. Pflughoeft KJ, Sumby P, Koehler TM. 2011. Bacillus anthracis sin locus and regulation of secreted proteases. J Bacteriol 193: 631-639. http://dx.doi.org/10.1128/JB.01083-10.
56. Rueff A-S, Chastanet A, Domínguez-Escobar J, Yao Z, Yates J, Prejean M-V, Delumeau O, Noirot P, Wedlich-Söldner R, Filipe SR, Carballido-López R. 2014. An early cytoplasmic step of peptidoglycan synthesis is associated to MreB in Bacillus subtilis. Mol Microbiol 91: 348-362. http://dx.doi.org/10.1111/mmi.12467.
57. Formstone A, Errington J. 2005. A magnesium-dependent mreB null mutant: implications for the role of mreB in Bacillus subtilis. Mol Microbiol 55: 1646-1657. http://dx.doi.org/10.1111/j.1365-2958.2005.04506.x.
58. Su M, He C, West CA, Mentzer SJ. 2001. Cytolytic peptides induce biphasic permeability changes in mammalian cell membranes. J Immunol Methods 252: 63-71. http://dx.doi.org/10.1016/S0022-1759(01)00334-9.
59. Chongsiriwatana NP, Barron AE. 2010. Comparing bacterial membrane interactions of antimicrobial peptides and their mimics. Methods Mol Biol 618: 171-182. http://dx.doi.org/10.1007/978-1-60761-594-1_12.
60. Sham LT, Barendt SM, Kopecky KE, Winkler ME. 2011. Essential PcsB putative peptidoglycan hydrolase interacts with the essential FtsXSpn cell division protein in Streptococcus pneumoniae D39. Proc Natl Acad Sci U S A 108: E1061-E1069. http://dx.doi.org/10.1073/pnas.1108323108.
61. Novak R, Charpentier E, Braun JS, Tuomanen E. 2000. Signal transduction by a death signal peptide: uncovering the mechanism of bacterial killing by penicillin. Mol Cell 5: 49-57. http://dx.doi.org/10.1016/S1097-2765(00)80402-5.
62. Yount NY, Yeaman MR. 2013. Peptide antimicrobials: cell wall as a bacterial target. Ann N Y Acad Sci 1277: 127-138. http://dx.doi.org/10.1111/nyas.12005.